We found that ST6GAL1 was significantly upregulated in tumor samples than in matched normal samples by analyzing fresh clinical samples from public databases (mean mRNA expression level: tumor vs. normal samples ═ 0.002712:0.000966, P < 0.05, n ═ 22). Here, ST6GAL1 is linked to neoplasm.